Reinheim, Germany

Guenter Moddelmog

This inventor holds 7 USPTO granted patents and 11 published patent applications, plus 6 CIPO patents and 9 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2013-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guenter Moddelmog. Retrieved from https://idiyas.com/inventor/guenter-moddelmog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 85.7

 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Guenter Moddelmog: Innovator in Pharmaceutical Patents

Introduction

Guenter Moddelmog is a notable inventor based in Reinheim, Germany. He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on innovative solutions that enhance the effectiveness and usability of pharmaceutical products.

Latest Patents

Among his latest patents is the invention of glycine particles. This invention relates to compacted glycine granules, where at least 75% of the granules have a particle size of above 0.7 mm. It also includes a process for the preparation and use of these granules. Another significant patent is for a direct injection moldable and rapidly disintegrating tablet matrix. This invention pertains to a novel directly compressible matrix for the production of tablets that disintegrate rapidly in the presence of moisture, particularly in the mouth.

Career Highlights

Guenter Moddelmog is currently associated with Merck Patent GmbH, where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to advancements that benefit both manufacturers and consumers.

Collaborations

Some of his notable coworkers include Thorsten Wedel and Roberto Ognibene. Their collaborative efforts contribute to the innovative environment at Merck Patent GmbH.

Conclusion

Guenter Moddelmog's contributions to pharmaceutical patents demonstrate his commitment to innovation and improvement in the industry. His inventions, particularly in glycine granules and rapidly disintegrating tablet matrices, highlight his role as a key figure in pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…